SINGAPORE, July 9 (Bloomberg): Singapore’s health minister dispelled concerns that a decision to not yet officially recognize Sinovac Biotech Ltd.’s vaccine would hamper quarantine-free travel plans, particularly with Hong Kong, saying that reciprocity between two places is more relevant in efforts to open up borders.
"That is really not the issue when it comes to opening up travel,” Ong Ye Kung said in response to a question on whether Sinovac’s status would hinder Singapore’s travel talks. The country has approved vaccines from Pfizer Inc. and Moderna Inc., but Sinovac’s shot isn’t part of the national vaccination program, so people inoculated with it don’t count in the government’s official tally.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
